In my last post, I talked about the hot M&A climate and how important it is to focus on supply chain integration during this process.
Because I'm involved in pharmaceutical consulting, I can think of no better example of the importance of understanding M&A right now than those organizations in the constantly evolving pharmaceutical industry. I prefer not to mention any particular organizations by name, but there are a few pharmaceutical companies that have wisely embraced the value of merging, acquiring or combining with companies that expand or complement their offerings. You read about it almost every day now.
It makes sense because a number of drug patents are getting ready to expire, generic drugs are more widely used today, and the time is ripe for expanding into emerging markets.
However, the pharma industry has some unique M&A challenges to overcome, including supply chain integration and channel diversity.
If you’d like to learn more, see the new article on M&A in the Pharmaceutical Industry: A Great Way to Rejuvenate.
Jim
Photo Credit: herval